Mjp Associates Inc Eli Lilly & CO Transaction History

Mjp Associates Inc

$484 Million
Q2 2024

A detailed history of Mjp Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mjp Associates Inc holds 3,004 shares of LLY stock, worth $2.71 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

3,004

Previous 2,994 0.33%

Holding current value

$2.71 Million

Previous $2.33 Million 16.75%

% of portfolio

0.56%

Previous 0.51%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $7,248 - $9,090	10 Added 0.33%	3,004 $2.72 Million
Q1 2024 Apr 11, 2024	BUY	$592.2 - $792.28 $357,688 - $478,537	604 Added 25.27%	2,994 $2.33 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $4,201 - $4,953	-8 Reduced 0.33%	2,390 $1.39 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $79,550 - $109,671	183 Added 8.26%	2,398 $1.29 Million
Q2 2023 Jul 11, 2023	BUY	$350.74 - $468.98 $211,145 - $282,325	602 Added 37.32%	2,215 $1.04 Million
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $12,735 - $14,957	41 Added 2.61%	1,613 $553,000
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $161,739 - $188,459	503 Added 47.05%	1,572 $0
Q3 2022 Oct 12, 2022	BUY	$296.48 - $337.87 $13,341 - $15,204	45 Added 4.39%	1,069 $346,000
Q2 2022 Jul 11, 2022	BUY	$278.73 - $327.27 $46,547 - $54,654	167 Added 19.49%	1,024 $332,000
Q1 2022 Apr 19, 2022	SELL	$234.69 - $291.66 $34,499 - $42,874	-147 Reduced 14.64%	857 $245,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $26,307 - $32,647	117 Added 13.19%	1,004 $273,000
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $3,767 - $4,636	17 Added 1.95%	887 $205,000
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $157,078 - $203,179	870 New	870 $200,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mjp Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mjp Associates Inc with notifications on news.

Account

Mjp Associates Inc Eli Lilly & CO Transaction History